Although systemic chemotherapy has been recognized as a standard treatment for gastric cancer with synchronous hepatic metastasis, the survival benefit of the therapy is still unsatisfactory. On the other hand, the local effect of intra-hepatic arterial chemotherapy (HAIC) is very high, and HAIC combined with systemic chemotherapy and surgery will be an effective therapy for selected patients. Here, we report a 39-year-old female case with advanced gastric cancer and synchronous liver metastasis. She has been treated with systemic chemotherapy, HAIC, and two operations. She has survived for 33 months now. The HAIC therapy will be a promising therapy in combination with systemic chemotherapy and/or surgery for gastric cancer with synchoromous liver metastasis.
|Number of pages||3|
|Journal||Gan to kagaku ryoho. Cancer & chemotherapy|
|Publication status||Published - Nov 2008|
All Science Journal Classification (ASJC) codes